Loading stock data…
Labcorp Holdings Inc. (LH)
$296.77+5.75 (+1.98%)
Market ClosedLast close Jul 24
Labcorp Holdings Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Labcorp Holdings Inc. in the Healthcare sector is trading at $296.77 with a market capitalization of $21.2B. Wall Street consensus targets $312.35 (17 analysts), implying a +5.3% move over the next 12 months. The stock is currently near its 52-week high of $298.58, remaining 11.4% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.54B↑ | $3.52B↓ | $3.56B↑ | $3.53B↑ | $3.35B |
| Gross Profit | $1.01B↑ | $993.20M↓ | $1.03B↓ | $1.05B↑ | $948.00M |
| Operating Income | $387.20M↑ | $382.00M↓ | $403.20M↑ | $398.60M↑ | $332.40M |
| Net Income | $277.80M↑ | $164.70M↓ | $261.10M↑ | $237.90M↑ | $212.80M |
Peer Comparison
JNJUNHPFE
Fundamentals
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.23B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.93
Beta
Defensive asset. Lower volatility than the S&P 500.
0.88
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.73%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.79%
Volume
Today's trading volume
776,997
Recent News
Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?
Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 9.7% over the past six months, topping the S&P 500 by 1.8 percentage points.
Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?
Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...